Publications

Browse Publications:

By Category:

• Abstract Posters (8)
• Research Papers (134)
• Presentations (6)

By Physician:

• David Charytan, MD (9)
• Donald E. Cutlip, MD (76)
• Ralph D'Agostino, PhD (15)
• Elazer R. Edelman, MD, PhD (5)
• Maurizio Fava, MD (5)
• Lawrence Garcia, MD (0)
• Ernest V. Gervino, Sc.D., FACSM (1)
• Michael Gibson, MD (4)
• Kalon K.L. Ho, MD, MSc (21)
• Michael Jaff, MD (0)
• Mark Josephson, MD (11)
• Joseph Massaro, PhD (18)
• Laura Mauri, MD (35)
• Andrew Nierenberg, MD (0)
• Mark H. Pollack, MD (1)
• Jeffrey J. Popma, MD (46)
• Matthew R. Reynolds, M.D, M.Sc. (18)
• Alexei Shvilkin, MD, PhD (14)
• Peter Zimetbaum, MD (30)

Publications From: Peter Zimetbaum, MD

Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol. 2009 Aug;2(4):362-9.

Vectorcardiographic determinants of cardiac memory during normal ventricular activation and continuous ventricular pacing. Heart Rhythm. 2009 Jul;6(7):943-8.

'Multiblock': what is the mechanism? Heart Rhythm. 2009 Jun;6(6):860-2.

Predicting irreversible left ventricular dysfunction after acute myocardial infarction. Am J Cardiol. 2009 May 1;103(9):1206-9.

Dronedarone for atrial fibrillation--an odyssey. N Engl J Med. 2009 Apr 30;360(18):1811-3.

Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol. Medicine (Baltimore). 2008 Nov;87(6):319-28.

A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol. 2008 Sep 30;52(14):1111-21.

Quality of life in atrial fibrillation: measurement tools and impact of interventions. J Cardiovasc Electrophysiol. 2008 Jul;19(7):762-8.

A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial. JACC Cardiovasc Interv. 2008 Jun;1(3):248-57.

Cardiovascular magnetic resonance characterization of mitral valve prolapse. JACC Cardiovasc Imaging. 2008 May;1(3):294-303.

Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation.... J Am Coll Cardiol. 2008 Feb 5;51(5):546-51.

Quality of Life in Atrial Fibrillation: Measurement Tools and Impact of Interventions. J Cardiovasc Electrophysiol. 2008 Feb 4

Coronary magnetic resonance vein imaging: imaging contrast, sequence, and timing. Magn Reson Med. 2007 Dec;58(6):1196-206.

Coronary magnetic resonance vein imaging: Imaging contrast, sequence, and timing. Magn Reson Med. 2007 Oct 29; [Epub ahead of print]

Predicting adverse outcomes in syncope. J Emerg Med. 2007 Oct;33(3):233-239.

Detailed intravascular ultrasound analysis of Zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial). Am J Cardiol. 2007 Sep 1;100(5):818-23.

Cardiac memory induced by QRS widening due to propafenone toxicity. Pacing Clin Electrophysiol. 2007 Sep;30(9):1161-4.

Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation. Arch Intern Med. 2007 Aug 13-27;167(15):1648-53.

Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J. 2007 Jul;28(14):1709-16.

Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry. J Cardiovasc Electrophysiol. 2007 Jun;18(6):628-33.

A 59-year-old man considering implantation of a cardiac defibrillator. JAMA. 2007 May 2;297(17):1909-16.

The yield of head CT in syncope: a pilot study. Intern Emerg Med. 2007 Mar;2(1):46-9.

Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation:.... Am Heart J. 2006 Dec;152(6):1097-103.

Bi-directional electrical pulmonary vein isolation as an endpoint for ablation of paroxysmal atrial fibrillation. J Interv Card Electrophysiol. 2006 Nov;17(2):111-7.

Restoring normal sinus rhythm in atrial fibrillation : evidence from pharmacologic therapy and catheter ablation trials. Curr Cardiol Rep. 2006 Sep;8(5):377-86.

Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry. Am J Cardiol. 2006 Feb 15;97(4):538-43.

Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction. Eur Heart J. 2005 Apr;26(7):667-74.

Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction:.... J Am Coll Cardiol. 2004 Sep 15;44(6):1215-23.

Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small coronary arteries: results of the Dilatation vs Ablation Revascularization Trial Targeting Restenosis (DART). Am Heart J. 2003 May;145(5):84

Use of Electrocardiogram in Acute Myocardial Infarction. N Engl J Med 2003 March 6;348:933-40.

Meet The HCRI Team

Jean Moses

Treasurer

A member of the senior management team since 2002, Ms. Moses focuses on Finance and Business Development. Under her supervision,…

Submit an RFP

Quick Links

• Contact HCRI
• Careers at HCRI
• Information for Patients

930-W Commonwealth Avenue
Boston MA 02215
t: 617.632.1515    f: 617.632.1580

©2009 Harvard Clinical Research Institute